Home / Directory / CAPSI - Cancer related major depression treated with a singl
Recruiting trial

CAPSI - Cancer related major depression treated with a single dose of psilocybin - a multicenter randomized placebo controlled double blind clinical trial

Goteborg, Orebro, Stockholm, Uppsala, Sweden · Ongoing, recruiting (EU CTIS)

Clinical trial authorised in the EU Clinical Trials Information System (CTIS). Condition: Major Depressive Disorder, Malignant tumours ICD 10 C00 to C97. Sponsor: Region Stockholm – SLSO. Sites: Sahlgrenska University Hospital-Vastra Gotalandsregionen (Goteborg); Uppsala University Hospital (Uppsala); Region Oerebro Laen (Orebro); Region Stockholm – SLSO (Stockholm). CTIS shows it as recruiting again from 26 Aug 2026; the estimated end date in the register (19 Dec 2025) has not been updated.

Trial listings come from public registries. Taking part is up to the study team, who will check your eligibility. Recruitment status can change at any time, so check the registry record first.

Type
Recruiting trial
Location
Goteborg, Orebro, Stockholm, Uppsala, Sweden
Status
Ongoing, recruiting (EU CTIS)
Registry
EU CTIS · 2023-505532-35-00
Sponsor
Region Stockholm – SLSO
Condition
Major Depressive Disorder, Malignant tumours ICD 10 C00 to C97
Website
https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2023-505532-35-00
Source
https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2023-505532-35-00
Last verified
19 November 2026

About this directory. Psyche Insights lists organisations for information only. A listing is not an endorsement, a recommendation or medical advice, and we do not take referral fees. We list only lawful, regulated services, registered clinical trials and professional training. We do not list retreats or anyone offering psychedelics outside the law. Psilocybin, MDMA, LSD and DMT are controlled drugs in the UK. Eligibility, availability and legal status differ by country and change often. Always check details with the provider or trial team, and talk to your GP or specialist before making any treatment decision. Paid placements are labelled “Featured · Paid placement” and never change our editorial descriptions. See our terms.

Corrections and removal. Spotted an error, or represent a listed organisation and want a listing corrected, updated or removed? Email [email protected] with the page link and the change needed. We aim to reply within 5 working days.

Follow access news each week

New trials, approvals and access routes, UK and Europe first.

Subscribe free →